As we proceed through the year, it is with great pleasure that we present the second edition of our Intellectual Property Newsletter for 2024. This quarter has witnessed a plethora of noteworthy devel...
Over the past couple of months, the healthcare industry has witnessed several regulatory developments ensuring best practices for clinical trials, stability studies for in-vitro diagnostics medical devices and implementation of good distribution practices. With extending the timelines for registration of medical devices, various sub-committees have also been set up to re-evaluate licensing conditions for selling and distribution of drugs and to revisit guidelines for over-the-counter drugs. In this edition of 'Checking the Pulse', we delve into key updates from April 2024 to May 2024 in the healthcare and pharmaceutical sectors, while also tapping on notable deals that have gained interest from the industry.
